Blood Market Report 2026

The blood market size has grown strongly in recent years. It will grow from $8.84 billion in 2025 to $9.38 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising incidence of surgical procedures, expansion of diagnostic laboratory networks, increasing awareness of blood safety protocols, growth of organized blood collection systems, improvements in blood screening technologies.

The blood market size is expected to see strong growth in the next few years. It will grow to $11.85 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to increasing demand for plasma-derived therapies, rising adoption of automated blood processing systems, expansion of national blood programs, growing use of data-driven blood supply management, increasing investments in transfusion safety technologies. Major trends in the forecast period include increasing demand for automated blood screening technologies, rising adoption of digital blood inventory management, growing focus on voluntary blood donation programs, expansion of plasma collection infrastructure, enhanced emphasis on blood safety and traceability.

The rising number of surgeries is anticipated to drive the growth of the blood market. This increase in surgeries is fueled by advancements in medical technology, an aging population, and a higher prevalence of chronic diseases. Blood plays a crucial role in surgery by delivering oxygen and nutrients, supporting clotting to control bleeding, and enhancing the immune response to fight infections. For example, in May 2025, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that in 2023-24, public hospitals admitted 778,500 patients for elective surgery, representing a 5.8% increase compared to 2022-23. Consequently, the growing number of surgeries is expected to propel the blood market forward.

Key players in the blood market are focusing on developing advanced blood transfusion devices, such as blood collection tubes, which enable the safe and efficient collection of whole blood and facilitate the easy separation of plasma from blood cells. A blood collection tube (BCT) is a specialized container designed to safely collect, transport, and store blood samples for laboratory testing or medical procedures, while maintaining the integrity of the blood and its components. For instance, in July 2025, OraSure Technologies, Inc., a US-based medical diagnostics and device company, through its subsidiary DNA Genotek, introduced the HEMAcollect PROTEIN Blood Collection Tube (BCT), a specialized device containing proprietary stabilizing liquid that preserves plasma proteins by reducing hemolysis and minimizes pre-analytical variability caused by cell lysis or platelet activation, thereby improving the reliability of downstream proteomic assays.

In March 2023, Werfen, a Spain-based medical equipment manufacturer, acquired Immucor Inc. for $2 billion. Through this acquisition, Werfen aims to broaden its portfolio of diagnostic solutions, especially in specialized diagnostics, enabling it to provide customers with a more comprehensive range of products, including hospitals, blood banks, and clinical laboratories. Immucor Inc. is a US-based company that develops, manufactures, and sells products used by hospitals, blood banks, and clinical laboratories to detect and identify the characteristics of human blood prior to transfusion.

Major companies operating in the blood market are Cardinal Health Inc., Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic Plc, Danaher Corp., Merck KGaA, Asahi Kasei Medical Co. Ltd., Henry Schein Inc., Medline Industries Inc., B. Braun Melsungen AG, Grifols SA, Terumo Corp., Nipro Corp., QuidelOrtho Corp., Bio Rad Laboratories Inc., LivaNova PLC, Haemonetics Corp., Macopharma, DIAGAST SAS, BAG Health Care GmbH, Kawasumi Laboratories America Inc.

North America was the largest region in the blood market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the blood market by increasing costs of imported blood collection bags, screening reagents, diagnostic instruments, cold storage equipment, and automated processing systems. Blood banks and diagnostic laboratories in North America and Europe are most affected due to reliance on imported consumables and equipment, while Asia-Pacific faces cost pressures on expanding screening infrastructure. These tariffs are raising operational costs and impacting procurement cycles. However, they are also encouraging local manufacturing of blood consumables, regional sourcing of reagents, and increased investment in domestic blood processing capabilities.

The blood market research report is one of a series of new reports that provides blood market statistics, including blood industry global market size, regional shares, competitors with a blood market share, detailed blood market segments, market trends and opportunities, and any further data you may need to thrive in the blood industry. This blood market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Blood is an essential bodily fluid that supports the proper functioning of organs. It consists of a complex combination of components, including red blood cells, white blood cells, platelets, and plasma, which contribute to maintaining health and facilitating medical treatments.

The primary products derived from blood include whole blood collection and processing, source plasma collection, blood typing products, and blood screening products. Whole blood collection and processing involves the collection, separation, and storage of whole blood, which contains red blood cells, white blood cells, platelets, and plasma. The various delivery forms include infusion solutions, gels, sprays, and biomedical sealants, which are utilized by different end users such as blood and blood component banks, diagnostic laboratories, ambulatory surgical centers, hospitals, and others.

The blood market consists of sales of blood bags, blood glucose analyzers, blood collection tubes, and blood transfusion sets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.